Zobrazeno 1 - 10
of 717
pro vyhledávání: '"Burghaus, R."'
Autor:
Dallmann A; Bayer HealthCare SAS, Loos, France.; Pharmacometrics/Modeling & Simulation, Research & Development, Pharmaceuticals, Bayer AG, Leverkusen, Germany., Teutonico D; Translational Medicine & Early Development, Sanofi-Aventis R&D, Vitry-sur-Seine, France., Schaller S; esqLABS GmbH, Saterland, Germany., Burghaus R; Pharmacometrics/Modeling & Simulation, Research & Development, Pharmaceuticals, Bayer AG, Leverkusen, Germany., Frechen S; Pharmacometrics/Modeling & Simulation, Research & Development, Pharmaceuticals, Bayer AG, Leverkusen, Germany.
Publikováno v:
Journal of clinical pharmacology [J Clin Pharmacol] 2024 Sep; Vol. 64 (9), pp. 1055-1067. Date of Electronic Publication: 2024 May 06.
Autor:
Burghaus, R.
For an ordered array of critical volatile wetting droplets the formation of a super lattice by an Ostwald-ripening like competition process is considered. The underlying diffusion problem is treated within a quasistatic approximation and to first ord
Externí odkaz:
http://arxiv.org/abs/cond-mat/9911468
Autor:
Burghaus, R.
The diffusional growth of wetting droplets on the boundary wall of a semi-infinite system is considered in different regions of a first-order wetting phase diagram. In a quasistationary approximation of the concentration field, a general growth equat
Externí odkaz:
http://arxiv.org/abs/cond-mat/9903107
Autor:
Frechen S; Pharmacometrics/Modeling and Simulation, Research and Development, Pharmaceuticals, Bayer AG, Leverkusen, Germany., Ince I; Pharmacometrics/Modeling and Simulation, Research and Development, Pharmaceuticals, Bayer AG, Leverkusen, Germany., Dallmann A; Pharmacometrics/Modeling and Simulation, Research and Development, Pharmaceuticals, Bayer AG, Leverkusen, Germany., Gerisch M; DMPK, Research and Development, Pharmaceuticals, Bayer AG, Leverkusen, Germany., Jungmann NA; DMPK, Research and Development, Pharmaceuticals, Bayer AG, Leverkusen, Germany., Becker C; Clinical Pharmacology, Research and Development, Pharmaceuticals, Bayer AG, Leverkusen, Germany., Lobmeyer M; Clinical Pharmacology, Research and Development, Pharmaceuticals, Bayer AG, Leverkusen, Germany., Trujillo ME; Merck & Co., Inc., Rahway, New Jersey, USA., Xu S; Merck & Co., Inc., Rahway, New Jersey, USA., Burghaus R; Pharmacometrics/Modeling and Simulation, Research and Development, Pharmaceuticals, Bayer AG, Leverkusen, Germany., Meyer M; Pharmacometrics/Modeling and Simulation, Research and Development, Pharmaceuticals, Bayer AG, Leverkusen, Germany.
Publikováno v:
CPT: pharmacometrics & systems pharmacology [CPT Pharmacometrics Syst Pharmacol] 2024 Jan; Vol. 13 (1), pp. 79-92. Date of Electronic Publication: 2023 Oct 12.
Autor:
Morcos PN; Bayer HealthCare Pharmaceuticals, Inc., Whippany, New Jersey, USA., Schlender J; Pharmacometrics/Modeling & Simulation, Pharmaceuticals Division, Bayer AG, Wuppertal, Germany., Burghaus R; Pharmacometrics/Modeling & Simulation, Pharmaceuticals Division, Bayer AG, Wuppertal, Germany., Moss J; BAST Inc. Limited, Leicester, UK., Lloyd A; BAST Inc. Limited, Leicester, UK., Childs BH; Bayer HealthCare Pharmaceuticals, Inc., Whippany, New Jersey, USA., Macy ME; Department of Pediatrics, University of Colorado and Center for Cancer and Blood Disorders, Children's Hospital Colorado, Aurora, Colorado, USA., Reid JM; Department of Pharmacology, Mayo Clinic Graduate School of Biomedical Sciences, Rochester, Minnesota, USA., Chung J; Bayer HealthCare Pharmaceuticals, Inc., Whippany, New Jersey, USA., Garmann D; Pharmacometrics/Modeling & Simulation, Pharmaceuticals Division, Bayer AG, Wuppertal, Germany.
Publikováno v:
Clinical and translational science [Clin Transl Sci] 2023 Jul; Vol. 16 (7), pp. 1197-1209. Date of Electronic Publication: 2023 Apr 18.
Autor:
Yassen A; Pharmacometrics/Modeling and Simulation, Research and Development, Pharmaceuticals, Bayer AG, Leverkusen, Germany.; Joint first authors., Coboeken K; Pharmacometrics/Modeling and Simulation, Research and Development, Pharmaceuticals, Bayer AG, Leverkusen, Germany.; Joint first authors., Bailly S; University Grenoble Alpes, Inserm, CHU Grenoble Alpes, Grenoble, France., Burghaus R; Pharmacometrics/Modeling and Simulation, Research and Development, Pharmaceuticals, Bayer AG, Leverkusen, Germany., Buskova J; National Institute of Mental Health, Klecany, Czech Republic., Dogas Z; Department of Neuroscience, Sleep Medicine Center, University of Split School of Medicine, Split, Croatia., Drummond M; Sleep and Non-Invasive Ventilation Unit of University Hospital São João, Medicine Faculty of Porto, Porto, Portugal., Gouveris H; ENT Department at Mainz University Hospital, Mainz, Germany., Joppa P; Department of Respiratory Medicine and Tuberculosis, Faculty of Medicine, P.J. Safarik University and L. Pasteur University Hospital, Kosice, Slovakia., Lippert J; Pharmacometrics/Modeling and Simulation, Research and Development, Pharmaceuticals, Bayer AG, Leverkusen, Germany., Lombardi C; Istituto Auxologico Italiano IRCCS, Sleep Disorders Center, San Luca Hospital, Milan, Italy.; Departmed of Medicine and Surgery, University of Milano-Bicocca, Milan, Italy., Mihaicuta S; Centre for Research and Innovation in Precision Medicine of Respiratory Diseases, Department of Pulmonology, 'Victor Babes' University of Medicine and Pharmacy, CardioPrevent Foundation, Timisoara, Romania., Pépin JL; University Grenoble Alpes, Inserm, CHU Grenoble Alpes, Grenoble, France., Zou D; Department of Internal Medicine and Clinical Nutrition, Center for Sleep and Wake Disorders, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden., Hedner J; Department of Internal Medicine and Clinical Nutrition, Center for Sleep and Wake Disorders, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.; Department of Pulmonary Medicine, Sleep Disorders Center, Sahlgrenska University Hospital, Gothenburg, Sweden.; Joint senior authors., Grote L; Department of Internal Medicine and Clinical Nutrition, Center for Sleep and Wake Disorders, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.; Department of Pulmonary Medicine, Sleep Disorders Center, Sahlgrenska University Hospital, Gothenburg, Sweden.; Joint first authors.
Publikováno v:
ERJ open research [ERJ Open Res] 2022 Oct 31; Vol. 8 (4). Date of Electronic Publication: 2022 Oct 31 (Print Publication: 2022).
Autor:
Nagamine T; Droice Research, New York, NY, USA., Gillette B; Department of Surgery, NYU Langone Long Island, Mineola, NY, USA.; Department of Foundations of Medicine, NYU Long Island School of Medicine, Mineola, NY, USA., Kahoun J; Droice Research, New York, NY, USA.; Clinical Informatics, CityMD, New York, NY, USA., Burghaus R; Bayer AG, Wuppertal, Germany., Lippert J; Bayer AG, Wuppertal, Germany., Saxena M; Droice Research, New York, NY, USA. mayur@droicelabs.com.
Publikováno v:
Scientific reports [Sci Rep] 2022 Oct 25; Vol. 12 (1), pp. 17871. Date of Electronic Publication: 2022 Oct 25.
Autor:
Marshall, SF1 scott.marshall@pfizer.com, Burghaus, R2, Cosson, V3, Cheung, SYA4, Chenel, M5, DellaPasqua, O6, Frey, N3, Hamrén, B7, Harnisch, L1, Ivanow, F8, Kerbusch, T9, Lippert, J2, Milligan, PA1, Rohou, S10, Staab, A11, Steimer, JL12, Tornøe, C13, Visser, SAG14
Publikováno v:
CPT: Pharmacometrics & Systems Pharmacology. Mar2016, Vol. 5 Issue 3, p93-122. 30p.
Autor:
Ince I; Clinical Pharmacometrics, Research & Development, Pharmaceuticals, Bayer AG, Germany., Solodenko J; Clinical Pharmacometrics, Research & Development, Pharmaceuticals, Bayer AG, Germany., Frechen S; Clinical Pharmacometrics, Research & Development, Pharmaceuticals, Bayer AG, Germany., Dallmann A; Clinical Pharmacometrics, Research & Development, Pharmaceuticals, Bayer AG, Germany., Niederalt C; Clinical Pharmacometrics, Research & Development, Pharmaceuticals, Bayer AG, Germany., Schlender J; Clinical Pharmacometrics, Research & Development, Pharmaceuticals, Bayer AG, Germany., Burghaus R; Clinical Pharmacometrics, Research & Development, Pharmaceuticals, Bayer AG, Germany., Lippert J; Clinical Pharmacometrics, Research & Development, Pharmaceuticals, Bayer AG, Germany., Willmann S; Clinical Pharmacometrics, Research & Development, Pharmaceuticals, Bayer AG, Germany.
Publikováno v:
Journal of clinical pharmacology [J Clin Pharmacol] 2019 Sep; Vol. 59 Suppl 1, pp. S95-S103.
Autor:
Schneider ARP; Institute of Applied Microbiology - iAMB, Aachen Biology and Biotechnology - ABBt, RWTH Aachen University, Aachen, Germany.; Systems Pharmacology & Medicine, Bayer AG, Leverkusen, Germany., Schneider CV; Division of Translational Medicine and Human Genetics, The Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA.; Department of Genetics, The Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA., Schneider KM; Department of Microbiology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA.; Institute for Immunology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA.; Institute for Diabetes, Obesity, and Metabolism, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA., Baier V; Institute of Applied Microbiology - iAMB, Aachen Biology and Biotechnology - ABBt, RWTH Aachen University, Aachen, Germany., Schaper S; Systems Pharmacology & Medicine, Bayer AG, Leverkusen, Germany., Diedrich C; Systems Pharmacology & Medicine, Bayer AG, Leverkusen, Germany., Coboeken K; Systems Pharmacology & Medicine, Bayer AG, Leverkusen, Germany., Mayer H; Systems Pharmacology & Medicine, Bayer AG, Leverkusen, Germany., Gu W; Medical Department I, Frankfurt University Hospital, Leverkusen, Germany., Trebicka J; Medical Department I, Frankfurt University Hospital, Leverkusen, Germany.; European Foundation for Study of Chronic Liver Failure, Barcelona, Spain., Blank LM; Institute of Applied Microbiology - iAMB, Aachen Biology and Biotechnology - ABBt, RWTH Aachen University, Aachen, Germany., Burghaus R; Clinical Pharmacometrics, Bayer AG, Wuppertal, Germany., Lippert J; Clinical Pharmacometrics, Bayer AG, Wuppertal, Germany., Rader DJ; Division of Translational Medicine and Human Genetics, The Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA.; Department of Genetics, The Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA., Thaiss CA; Department of Microbiology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA.; Institute for Immunology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA.; Institute for Diabetes, Obesity, and Metabolism, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA., Schlender JF; Systems Pharmacology & Medicine, Bayer AG, Leverkusen, Germany., Trautwein C; Department of Medicine III, University Hospital Aachen, Aachen, Germany., Kuepfer L; Institute for Systems Medicine, University Hospital RWTH Aachen, Aachen, Germany.
Publikováno v:
Liver international : official journal of the International Association for the Study of the Liver [Liver Int] 2022 Mar; Vol. 42 (3), pp. 640-650. Date of Electronic Publication: 2022 Feb 03.